ARTICLE | Company News
Pharmos gastrointestinal news
October 26, 2009 7:00 AM UTC
Pharmos retained Cowen & Co. to assist in finding partnerships for its dextofisopam after the R-isomer of racemic tofisopam missed the primary endpoint in a Phase IIb trial to treat irritable bowel s...